The role of the transplant physician in the management of skin cancers after organ transplantation.
Morelon
Emmanuel
E
Département de Transplantation, Université Claude-Bernard Lyon 1, Hôpital Edouard Herriot, Pavillon P, Lyon, France.
Mahe
Emmanuel
E
Touraine
Jean-Louis
JL
D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins / Q000378:metabolism; D007668:Kidney / Q000187:drug effects; D008495:Medical Oncology / Q000379:methods; D016377:Organ Transplantation / Q000009:adverse effects*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D012306:Risk; D012514:Sarcoma, Kaposi / Q000209:etiology / Q000628:therapy; D012878:Skin Neoplasms / Q000209:etiology* / Q000628:therapy*; D058570:TOR Serine-Threonine Kinases
D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; C546842:MTOR protein, human; D017346:Protein Serine-Threonine Kinases; D058570:TOR Serine-Threonine Kinases